NCT00537745

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders-a Pilot Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Pacific Institute for Research and Evaluation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.

Detailed description

We propose to conduct an open label trial of Vivitrol in combination with an individual compliance enhancement therapy known as Medication Management Therapy (MMT) as an adjunct to Ignition Interlock in the management and treatment of DWI. Subjects will be recruited from a local Interlock provider. This program of research will collect pilot data for a study to determine whether pharmacotherapy, previously recognized as effective, can be successfully combined with existing counseling treatments and sanctions for persons convicted of a repeat DWI alcohol offense. We will investigate the extent to which this combination of sanctions and treatment will significantly decrease attempts to drive after drinking among offenders, and whether the effect persists following discontinuation of Vivitrol.

Conditions

• Alcohol Consumption

Interventions

Type	Name	Description
DRUG	Vivitrol (Medication Therapy)	Vivitrol 380 mg/monthly
OTHER	Medication Management Therapy	Medication Management Therapy once a month.

Timeline

• Start date: 2007-04-01
• Primary completion: 2009-05-01
• Completion: 2009-05-01
• First posted: 2007-10-01
• Last updated: 2012-08-27
• Results posted: 2012-08-27

Locations

1 site across 1 country: United States